Episode Details

Back to Episodes
HSE Drugs Group recommends not funding Friedreich’s Ataxia drug

HSE Drugs Group recommends not funding Friedreich’s Ataxia drug

Published 2 weeks, 5 days ago
Description

The HSE Drugs Group has decided to recommend not funding the drug Skyclarys for the rare condition Friedreich's Ataxia. Around 200 people have this disease in Ireland.

Pádraig O'Sullivan is Fianna Fáil TD for Cork North Central and joins Shane to discuss.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us